dbACP: A Comprehensive Database of Anti-Cancer Peptides

157 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp00043 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 12.9% inhibition at 10-6 M
dbacp00044 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 16.5% inhibition at 10-5 M
dbacp00045 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 28.1% inhibition at 10-4 M
dbacp00046 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 58.2% inhibition at 10-3 M
dbacp00067 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 10.5% inhibition at 10-6 M
dbacp00068 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 21.9% inhibition at 10-5 M
dbacp00069 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 11.8% inhibition at 10-4 M
dbacp00070 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 17.9% inhibition at 10-3 M
dbacp00094 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 10.7% inhibition at 10-6 M
dbacp00095 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 10.0% inhibition at 10-5 M
dbacp00141 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 13.6% inhibition at 10-6 M
dbacp00142 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 20.4% inhibition at 10-5 M
dbacp00143 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 14.4% inhibition at 10-4 M
dbacp00144 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 23.4% inhibition at 10-3 M
dbacp00174 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 17.0% inhibition at 10-6 M
dbacp00175 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 13.5% inhibition at 10-5 M
dbacp00176 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 13.5% inhibition at 10-4 M
dbacp00177 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 25.3% inhibition at 10-3 M
dbacp00208 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 12.2% inhibition at 10-6 M
dbacp00209 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 15.5% inhibition at 10-5 M
dbacp00210 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 24.7% inhibition at 10-4 M
dbacp00211 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 29.0% inhibition at 10-3 M
dbacp00242 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 26.4% inhibition at 10-6 M
dbacp00243 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 13.1% inhibition at 10-5 M
dbacp00244 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 14.6% inhibition at 10-4 M
dbacp00245 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 38.4% inhibition at 10-3 M
dbacp00768 A specific Eps8/EGFR Inhibitor Peptide 327 EFLDCFQKF A specific Eps8/EGFR Inhibitor Peptide 327 Immune response to tumor cell recognition Lactate dehydrogenase (LDH)-release assay SW620 Colon cancer IC50 : 102.35 ± 4.66 μM
dbacp00776 A12L KWKSFLKTFKSLKKTVLHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay SW-1116 Colorectal cancer IC50 : 6.4 µMo/L
dbacp00784 A12L/A20L KWKSFLKTFKSLKKTVLHTLLKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay SW-1116 Colorectal cancer IC50 : 4.3 µMo/L
dbacp00792 A12L/A20L/A23L KWKSFLKTFKSLKKTVLHTLLKLISS PeptideV13K Membrane disruption mechanism MTT/MTS assay SW-1116 Colorectal cancer IC50 : 3.5 µMo/L
dbacp00800 A20L KWKSFLKTFKSAKKTVLHTLLKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay SW-1116 Colorectal cancer IC50 : 5 µMo/L
dbacp01948 Brevinin-1RL1 FFPLIAGLAARFLPKIFCSITKRC Not found Inducing apoptosis Cell death assay SW480 Not specified IC50 : 10.37 ± 0.40 μM
dbacp01968 Brevinin-2R KLKNFAKGVAQSLLNKASCKLSGQC Skin, Marsh frog, Europe Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death MTT-assay SW742 Colon carcinoma LD50 : 10 – 15 μg/ml
dbacp01969 Brevinin-2R KLKNFAKGVAQSLLNKASCKLSGQC Skin, Marsh frog, Europe Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death MTT-assay SW742 Colon carcinoma LD50 : 20 – 25 μg/ml
dbacp01970 Brevinin-2R KLKNFAKGVAQSLLNKASCKLSGQC Skin, Marsh frog, Europe Activates the lysosomal-mitochondrial death pathway; Involves autophagy-like cell death MTT-assay SW742 Colon carcinoma LD50 : 30 – 40 μg/ml
dbacp02044 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SW-620 Colon cancer IC50 : 12.7 µg/ml
dbacp02102 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SW-620 Not specified IC50 : 12.7 µg/ml
dbacp03190 HAL-1 GMWSKILGHLIR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 44 ± 8 µM
dbacp03193 HAL-1/10 GMWKKILGKLIR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 60 µM
dbacp03196 HAL-1/12 GKWSKILGHLIR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp03199 HAL-1/15 GMWSKLLGHLLR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 40 µM
dbacp03202 HAL-1/17 KMWSKILGHLIR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp03205 HAL-1/18 GMWSKILKHLIR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 18 ± 2 µM
dbacp03208 HAL-1/19 GKWKKILGHLIR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp03211 HAL-1/20 GKWSKILGKLIR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 40 µM
dbacp03214 HAL-1/21 GKWKKILGKLIR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp03217 HAL-1/22 gmwskilghlir Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 40 µM
dbacp03220 HAL-1/29 GMWSKILGHLIR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer Not found
dbacp03223 HAL-1/4 GMWSKILGHLKR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer Not found
dbacp03226 HAL-1/5 GMWKKILGHLIR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 44 ± 5 µM
dbacp03229 HAL-1/6 GMWSKILGHLIK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp03232 HAL-1/9 GMWSKILGKLIR Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 50 µM
dbacp03235 HAL-2 GKWMSLLKHILK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 35 ± 3 µM
dbacp03238 HAL-2/1 GKWKSLLKHILK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp03241 HAL-2/11 GKWLSLLKHILK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 40 µM
dbacp03244 HAL-2/13 GKWMTLLKHILK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 60 µM
dbacp03247 HAL-2/18 GKWMSLLKHIWK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 40 µM
dbacp03250 HAL-2/19 GKWMSLLKHWLK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 40 µM
dbacp03253 HAL-2/2 GKWMKLLKHILK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 35 ± 5 µM
dbacp03256 HAL-2/20 GKWMSLWKHILK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 40 µM
dbacp03259 HAL-2/22 gkwmsllkhilk Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp03262 HAL-2/24 GKFMSLLKHILK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 40 µM
dbacp03265 HAL-2/4 GKWMSLLKKILK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 38 ± 6 µM
dbacp03268 HAL-2/6 GKWMSFLKHILK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 40 µM
dbacp03271 HAL-2/8 GKWMSLLKHILK Sweat bees and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 40 µM
dbacp03535 L-amino oxidase (CP-LAAO) (LAO) (EC 1.4.3.2) MNVFFMFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIARXXXXTSNPKHVVRVGAGMSGLSAAYVLAGAGHQVTVLEASERPGGRXXXXXXXXEGWYANLGPMRXXXXXXXXXXXXXKFGLNLNEFSQENDNAWYFIKXXXXXXXXXXDPGLLKYPVKPSEAGKSAGQLYEESLGKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFDEIVDGMDKLPTSMYQAIXXXXXXXXXXXXXXXXXXKVTVTYQTPAKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIFLTCTKKFWEDDGIHGGKSTTDLPSRXXXXXXXXXXXXXXVIIAYGIGDDANFFQALDFKDCADIVFNDLSLIHQLPKEEIPSFCYPSMIQKXXXXXXXXXXITTFFTPYQFQHFSEAXXXXXXXIYFAGEYTAQAHGWIDSTIK Mangrove pit viper Cytotoxic; Anti-proliferative; Apoptosis Not specified SW480 Colon cancer EC50 : 29.43 ± 0.48
dbacp03536 L-amino oxidase (CP-LAAO) (LAO) (EC 1.4.3.2) MNVFFMFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIARXXXXTSNPKHVVRVGAGMSGLSAAYVLAGAGHQVTVLEASERPGGRXXXXXXXXEGWYANLGPMRXXXXXXXXXXXXXKFGLNLNEFSQENDNAWYFIKXXXXXXXXXXDPGLLKYPVKPSEAGKSAGQLYEESLGKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFDEIVDGMDKLPTSMYQAIXXXXXXXXXXXXXXXXXXKVTVTYQTPAKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIFLTCTKKFWEDDGIHGGKSTTDLPSRXXXXXXXXXXXXXXVIIAYGIGDDANFFQALDFKDCADIVFNDLSLIHQLPKEEIPSFCYPSMIQKXXXXXXXXXXITTFFTPYQFQHFSEAXXXXXXXIYFAGEYTAQAHGWIDSTIK Mangrove pit viper Cytotoxic; Anti-proliferative; Apoptosis Not specified SW620 Colon cancer EC50 : 23.19 ± 1.57
dbacp03573 L17A KWKSFLKTFKSAKKTVAHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay SW-1116 Colorectal cancer IC50 : > 83.6 µMo/L
dbacp03581 L17A/L21A KWKSFLKTFKSAKKTVAHTAAKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay SW-1116 Colorectal cancer IC50 : > 83.6 µMo/L
dbacp03592 L21A KWKSFLKTFKSAKKTVAHTAAKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay SW-1116 Colorectal cancer IC50 : >83.6 µMo/L
dbacp03616 L6A KWKSFAKTFKSAKKTVLHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay SW-1116 Colorectal cancer IC50 : >83.6 µMo/L
dbacp03624 L6A/L17A KWKSFAKTFKSAKKTVAHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay SW-1116 Colorectal cancer IC50 : >83.6 µMo/L
dbacp03687 Lasioglossin LL-III VNWKKILGKIIKVVK Broad-faced Furrow Bee Cell membrane disintegration MTT test SW480 Not found IC50 : 15.0 μM
dbacp04181 LL-III VNWKKILGKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 18 ±4 µM
dbacp04184 LL-III/1 VNWKKILAKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 12 ± 3 µM
dbacp04187 LL-III/10 KNWKKILGKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer Not found
dbacp04190 LL-III/11 VNWKKIILGKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 48 µM
dbacp04193 LL-III/12 vnwkkilgkiikvvk Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 20 µM
dbacp04196 LL-III/15 VNFKKLLGKLLKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 42 µM
dbacp04199 LL-III/16 VN-NAl-KKLLGKLLKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer Not found
dbacp04202 LL-III/17 VNWRRILGRIIRVVR Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer Not found
dbacp04205 LL-III/18 KNWKKILKKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer Not found
dbacp04208 LL-III/19 VNWKK-Aib-LGK-Aib-IK-Aib-VK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 28 µM
dbacp04211 LL-III/2 NVWKKILGKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 11 µM
dbacp04214 LL-III/22 KNWKK-Aib-LKK-Aib-IK-Aib-VK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp04217 LL-III/23 VNWKKLLGKLLKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 15 µM
dbacp04220 LL-III/24 VNWOOILGOIIOVVO Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 20 µM
dbacp04223 LL-III/25 vnwkkllgkllkvvk Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 20 µM
dbacp04226 LL-III/26 VYWKKILGKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 30 µM
dbacp04229 LL-III/27 VNWKKVLGKVVKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp04232 LL-III/3 VNWKKILKKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 40 µM
dbacp04235 LL-III/34 NKWKKILGKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 37 µM
dbacp04238 LL-III/36 VNWKKILAKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer Not found
dbacp04240 LL-III/37 VNWKKILGKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 5 ± 1 µM
dbacp04241 LL-III/37 VNWKKILGKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 13 µM
dbacp04244 LL-III/4 VNWKKILGKIKKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 40 µM
dbacp04247 LL-III/6 VNWKKILPKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer Not found
dbacp04250 LL-III/8 VNWKKILGKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer Not found
dbacp04253 LL-III/9 VNWKKILGKIIKVVK Lasioglossin III and its analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 25 ± 5 µM
dbacp04283 Lovastatin nonaketide synthase MAQSMYPNEPIVVVGSGCRFPGDANTPSKLWELLQHPRDVQSRIPKERFDVDTFYHPDGKHHGRTNAPYAYVLQDDLGAFDAAFFNIQAGEAESMDPQHRLLLETVYEAVTNAGMRIQDLQGTSTAVYVGVMTHDYETVSTRDLESIPTYSATGVAVSVASNRISYFFDWHGPSMTIDTACSSSLVAVHLAVQQLRTGQSSMAIAAGANLILGPMTFVLESKLSMLSPSGRSRMWDAGADGYARGEAVCSVVLKTLSQALRDGDTIECVIRETGVNQDGRTTGITMPNHSAQEALIKATYAQAGLDITKAEDRCQFFEAHGTGTPAGDPQEAEAIATAFFGHEQVARSDGNERAPLFVGSAKTVVGHTEGTAGLAGLMKASFAVRHGVIPPNLLFDKISPRVAPFYKNLRIPTEATQWPALPPGQPRRASVNSFGFGGTNAHAIIEEYMEPEQNQLRVSNNEDCPPMTGVLSLPLVLSAKSQRSLKIMMEEMLQFLQSHPEIHLHDLTWSLLRKRSVLPFRRAIVGHSHETIRRALEDAIEDGIVSSDFTTEVRGQPSVLGIFTGQGAQWPGMLKNLIEASPYVRNIVRELDDSLQSLPEKYRPSWTLLDQFMLEGEASNVQYATFSQPLCCAVQIVLVRLLEAARIRFTAVVGHSSGEIACAFAAGLISASLAIRIAYLRGVVSAGGARGTPGAMLAAGMSFEEAQEICELDAFEGRICVAASNSPDSVTFSGDANAIDHLKGMLEDESTFARLLKVDTAYHSHHMLPCADPYMQALEECGCAVADAGSPAGSVPWYSSVDAENRQMAARDVTAKYWKDNLVSPVLFSHAVQRAVVTHKALDIGIEVGCHPALKSPCVATIKDVLSGVDLAYTGCLERGKNDLDSFSRALAYLWERFGASSFDADEFMRAVAPDRPCMSVSKLLPAYPWDRSRRYWVESRATRHHLRGPKPHLLLGKLSEYSTPLSFQWLNFVRPRDIEWLDGHALQGQTVFPAAGYIVMAMEAALMIAGTHAKQVKLLEILDMSIDKAVIFDDEDSLVELNLTADVSRNAGEAGSMTISFKIDSCLSKEGNLSLSAKGQLALTIEDVNPRTTSASDQHHLPPPEEEHPHMNRVNINAFYHELGLMGYNYSKDFRRLHnMQRADLRASGTLDFIPLMDEGNGCPLLLHPASLDVAFQTVIGAYSSPGDRRLRCLYVPTHVDRITLVPSLCLATAESGCEKVAFNTINTYDKGDYLSGDIVVFDAEQTTLFQVENITFKPFSPPDASTDHAMFARWSWGPLTPDSLLDNPEYWATAQDKEAIPIIERIVYFYIRSFLSQLTLEERQQAAFHLQKQIEWLEQVLASAKEGRHLWYDPGWENDTEAQIEHLCTANSYHPHVRLVQRVGQHLLPTVRSNGNPFDLLDHDGLLTEFYTNTLSFGPALHYARELVAQIAHRYQSMDILEIGAGTGGATKYVLATPQLGFNSYTYTDISTGFFEQAREQFAPFEDRMVFEPLDIRRSPAEQGFEPHAYDLIIASNVLHATPDLEKTMAHARSLLKPGGQMVILEITHKEHTRLGFIFGLFADWWAGVDDGRCTEPFVSFDRWDAILKRVGFSGVDSRTTDRDANLFPTSVFSTHAIDATVEYLDAPLASSGTVKDSYPPLVVVGGQTPQSQRLLNDIKAIMPPRPLQTYKRLVDLLDAEELPMKSTFVMLTELDEELFAGLTEETFEATKLLLTYASNTVWLTENAWVQHPHQASTIGMLRSIRREHPDLGVHVLDVDAVETFDATFLVEQVLRLEEHTDELASSTTWTQEPEVSWCKGRPWIPRLKRDLARNNRMNSSRRPIYEMIDSSRAPVALQTARDSSSYFLESAETWFVPESVQQMETKTIYVHFSCPHALRVGQLGFFYLVQGHVQEGNREVPVVALAERNASIVHVRPDYIYTEADNNLSEGGGSLMVTVLAAAVLAETVISTAKCLGVTDSILVLNPPSICGQMLLHAGEEIGLQVHLATTSGNRSSVSAGDAKSWLTLHARDTDWHLRRVLPRGVQALVDLSADQSCEGLTQRMMKVLMPGCAHYRAADLFTDTVSTELHSGSRHQASLPAAYWEHVVSLARQGLPSVSEGWEVMPCTQFAAHADKTRPDLSTVISWPRESDEATLPTRVRSIDAETLFAADKTYLLVGLTGDLGRSLGRWMVQHGACHIVLTSRNPQVNPKWLAHVEELGGRVTVLSMDVTSQNSVEAGLAKLKDLHLPPVGGIAFGPLVLQDVMLNnMELPMMEMVLNPKVEGVRILHEKFSDPTSSNPLDFFVMFSSIVAVMGNPGQANYSAANCYLQALAQQRVASGLAASTIDIGAVYGVGFVTRAELEEDFNAIRFMFDSVEEHELHTLFAEAVVAGRRAVHQQEQQRKFATVLDMADLELTTGIPPLDPALKDRITFFDDPRIGNLKIPEYRGAKAGEGAAGSKGSVKEQLLQATNLDQVRQIVIDGLSAKLQVTLQIPDGESVHPTIPLIDQGVDSLGAVTVGTWFSKQLYLDLPLLKVLGGASITDLANEAAARLPPSSIPLVAATDGGAESTDNTSENEVSGREDTDLSAAATITEPSSADEDDTEPGDEDVPRSHHPLSLGQEYSWRIQQGAEDPTVFNNTIGMFMKGSIDLKRLYKALRAVLRRHEIFRTGFANVDENGMAQLVFGQTKNKVQTIQVSDRAGAEEGYRQLVQTRYNPAAGDTLRLVDFFWGQDDHLLVVAYHRLVGDGSTTENIFVEAGQLYDGTSLSPHVPQFADLAARQRAMLEDGRMEEDLAYWKKMHYRPSSIPVLPLMRPLVGNSSRSDTPNFQHCGPWQQHEAVARLDPMVAFRIKERSRKHKATPMQFYLAAYQVLLARLTDSTDLTVGLADTNRATVDEMAAMGFFANLLPLRFRDFRPHITFGEHLIATRDLVREALQHARVPYGVLLDQLGLEVPVPTSNQPAPLFQAVFDYKQGQAESGTIGGAKITEVIATRERTPYDVVLEMSDDPTKDPLLTAKLQSSRYEAHHPQAFLESYMSLLSMFSMNPALKLA Soil mold Induce G1 arrest and increased apoptotic cell populations at the sub-G1 phase MTT assay SW1736 Human anaplastic thyroid cancer MIC : 0 – 20 µM
dbacp04285 Lovastatin nonaketide synthase, polyketide synthase component MAQSMYPNEPIVVVGSGCRFPGDANTPSKLWELLQHPRDVQSRIPKERFDVDTFYHPDGKHHGRTNAPYAYVLQDDLGAFDAAFFNIQAGEAESMDPQHRLLLETVYEAVTNAGMRIQDLQGTSTAVYVGVMTHDYETVSTRDLENIPTYSATGVAVSVASNRISYFFDWHGPSMTIDTACSSSLVAVHLAVQQLRTGQSSMAIAAGANLILGPMTFVLESKLSMLSPSGRSRMWDAGADGYARGEAVCSVVLKTLSQALRDGDTIECVIRETGVNQDGRTTGITMPNHSAQEALIKATYAQAGLDITKAEDRCQFFEAHGTGTPAGDPQEAEAIATAFFGHEQVARSDGNERAPLFVGSAKTVVGHTEGTAGLAGLMKASFAVRHGVIPPNLLFDKISPRVAPFYKNLRIPTEATQWPALPPGQPRRASVNSFGFGGTNAHAIIEEYMEPEQNQLRVSNNEDCPPMTGVLSLPLVLSAKSQRSLKIMMEEMLQFLETHPEIHLHDLTWSLLRKRSVLPFRRAIVGHSHETIRRALEDAIEDGIVSSDFTTEVRGQPSVLGIFTGQGAQWPGMLKNLIEASPYVRSIVRELDDSLQSLPEKYRPSWTLLDQFMLEGEASNVQYASFSQPLCCAVQIVLVRLLEAARIRFTAVVGHSSGEIACAFAAGLISASVAIRIAYLRGVVSAGGARGTPGAMLAAGMSFEEAQEICELDAFEGRICVAASNSPDSVTFSGDANAIDHLKSMLEDESTFARLLRVDTAYHSHHMLPCADPYMQALEECGCAVADAGSPAGSVPWYSSVNAENRQMAARDVTAEYWKDNLVSPVLFSHAVQRAVVTHKALDIGIEVGCHPALKSPCVATIKDVLSGVDLAYTGCLERGKNDLDTFSRALAYLWERFGASSFDADEFMRAVAPDRPCMSVSKLLPAYPWDHSRRYWVESRATRHHLRGPKPHLLLGKLSEYSTPLSFQWLNFVRPRDIEWLDGHALQGQTVFPAAGYIVMAMEAALMIAGTHAKQVQLLEILDMSIDKAVIFDDEDSLVELNLTADVSRNAGEAGSMTISFKIDSCLSKEGNLSLSAKGQLALMIGDVNSRTTSASDQHHLPPPEEEHPHMNRVNIKAFYHELGLMGYNYSKDFRRLHnMQRADLRASGTIDFIPLMDEGNGCPLLLHPASLDVAFQTVIGAYSSPGDRRLRCLYVPTHVDRITLVPSLCLATAESGCEKVAFNTINTYDKGDYLSGDIAVFDAEQTTLFQVENITFKPFSPPDASTDHAMFARWSWGPLTPDSLLDNPEYWATAQDKEAIPIIERIVYFYIRSFLNQLTLEERQKAAFHLQKQIEWLEQVLASAKEGRHLWYDPGWENDTEAQIEHLCTANSYHPHVRLVQRVGQHLLPTVRSNGNPFDLLDHDGLLTEFYTNTLSFGPALHYARELVAQIAHRYQSMDILEIGAGTGGATKYVLATPQLGFNSYTYTDISTGFFEQAREQFAPFEDRMVFEPLDIRRSPAEQGFETHAYDLIIASNVLHATPDLEKTMAHARSLLKPGGQMVILEITHKEHTRLGFIFGLFADWWAGVDDGRCTEPFVSFDRWDAILKRVGFSGVDSRTTDRDANLFPTSVFSTHAIDATVEYLDAPLASSGTVKDSYPPLVVVGGQTPKSQRLLNDIKAIMPPRPLQTYKRLVDLLDAEELPMKSTFVMLTELDEELFAGLTEETFEATKLLLTYSSNTVWLTENAWVQHPHQASTIGMLRSIRREHPDLGVHVLDVDAVETFDATFLVEQVLRLEEHTDELASSTTWTQEPEVSWCKGRPWIPRLKRDLARNNRMNSSRRPIYEMIDSSRAPVALQTAPDSSSYFLESAETWFVPESVRQMETKTVYVHFSCPHALRVGQLGFFYLVQGHVQEGNREVPVVALAERNASIVHVRPDYIYTEADNNLSEGGGSLIVTVLAAAVLAETVISTAKSLGVTDSILVLNPPSICGQMLLHAGEEIGLQVHLATTSGNRSSVSAGDAKSWLTLHARDTDWHLRRVLPRGVQAFVDLSADQSCECLTQRMMKVLMPGCAHYRAADLFTDTVSTELHRGLRHQASLPAAYWEHVVSLARQGLSSVSEGWEVMPCTQFAAHADKTRPDLSTVISWPRESDKATLPTRVRSIDAETLFAADKTYLLVGLTGDLGRSLGRWMVQHGACHIVLTSRNPQVNPKWLAHVEELGGRVTVLSMDVTSENSVDAGLAKIKDLHLPPVGGIAFGPLVLQDVMLKnMELPMMEMVLNPKVEGVRILHEKFSDPTSSNPLDFFVMFSSIVAVMGNPGQANYSAANCYLQALAQQRVASGLAASTIDIGAVYGVGFVTRAELEEDFNAIRFMFDSVEEHELHTLFAEAVVAGRRAVHQQEQQRKFATVLDMADLELTTGIPPLDPALKDRITFFDDPRIGNLKIPEYRGAKAGEGAAGSKGSVKEQLLQATNLDQVRQIVIDGLSAKLQVTLQIPDGESVHPTISLIDQGVDSLGAVTVGTWFSKQLYLDLPLLKVLGGASIADLADEAAARLPPSSIPLVAATDGGAESTDNTSENEVSGREDTDLSAAATITEPSSADEDDTEPGDEDVPRSHHPLSLGQEYSWRIQQGAEDPTVFNNTIGMFMKGPIDLKRLYKALRAVLRRHEIFRTGFANVDENGMAQLVFGQTKNKVQTIQVSDRAGAEEGYRQLVQTRYNPAAGDTLRLVDFFWGQDDHLLVVAYHRLVGDGSTTENIFVEAGQLYDGRSLSPRVPQFADLAARQRAMLEDGRMEEDLAYWKEMHQRPSSIPVLPLMRPLVGNSSTSNTPNFQHCGSWQQHEAVARLDPMVAFRIKERSRKHKATPMQFYLAAYQVLLARLTDSTDLTVGLADTNRATVDEMAAMGFFANLLPLRFRDFRPHITFGEHLIATRDLVREALQHARVPYGVLLDQLGLEVPVPTSNQPAPLLQAVFDYKQGQAESGTIGGAKITEVIATRERTPYDVVLEMSDDPTKDPLLTAKLQSSRYEAHHPQAFLESYMSLLSMFSMNPALKLA Soil mold (strain NIH 2624 / FGSC A1156) Induce G1 arrest and increased apoptotic cell populations at the sub-G1 phase MTT assay SW1736 Human anaplastic thyroid cancer MIC : 0 – 20 µM
dbacp04377 MAC1 GFGMALKLLKKVL Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 23 ± 4 µM
dbacp04380 MAC1/1 gfgmalkllkkvl Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 19 ± 2 µM
dbacp04383 MAC1/10 GFKMALKLLKKVL Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer Not found
dbacp04386 MAC1/16 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp04389 MAC1/19 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 68 ± 2 µM
dbacp04392 MAC1/2 AFGMALKLLKKVL Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 16 µM
dbacp04395 MAC1/20 GFGMALOLLOOVL Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 35 ± 4 µM
dbacp04398 MAC1/21 GFGMALRLLRRVL Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 17 ± 2 µM
dbacp04401 MAC1/24 GFGMALKL-(AC6C)-KKVL Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 16 ± 1 µM
dbacp04404 MAC1/25 GFGMALK-(AC6C)-LKKVL Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 14 ± 1 µM
dbacp04407 MAC1/26 GFGMA-(AC6C)-KLLKKVL Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 18 ± 1 µM
dbacp04410 MAC1/3 LFGMALKLLKKVL Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 11 ± 1 µM
dbacp04413 MAC1/4 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 49 ± 9 µM
dbacp04416 MAC1/6 GFGMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 29 ± 3 µM
dbacp04419 MAC1/9 GFKMALKLLKKVL-NH2 Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : 13 ± 3 µM
dbacp04422 MAC2 GTGLPMSERRKIMLMMR Wallabies and their analogs Cell membrane damage MTT/MTS assay SW Colon cancer IC50 : > 100 µM
dbacp04428 Macropin 1 GFGMALKLLKKVL The solitary bee Cell membrane disintegration MTT/XTT test SW Not found IC50 : 23 ± 4 μM
dbacp04435 Macropin 2 GTGLPMSERRKIMLMMR The solitary bee Cell membrane disintegration MTT/XTT test SW Not found IC50 : >100 μM
dbacp04794 N29D PDEDAINDALNKVCSTGRRQRSICKQLLKK Synthetic peptide Apoptotic inducing Cell viability assay SW-480 Colon cancer > 100% cell viability at 5 µM
dbacp04795 N29D PDEDAINDALNKVCSTGRRQRSICKQLLKK Synthetic peptide Apoptotic inducing Cell viability assay SW-480 Colon cancer 60% cell viability at 50 µM
dbacp04800 N29D PDEDAINDALNKVCSTGRRQRSICKQLLKK Synthetic peptide Apoptotic inducing Cell viability assay SW-480 Colon cancer > 100% cell viability at 5 µM
dbacp04801 N29D PDEDAINDALNKVCSTGRRQRSICKQLLKK Synthetic peptide Apoptotic inducing Cell viability assay SW-480 Colon cancer 60% cell viability at 50 µM
dbacp04806 N29N PDEDAINNALNKVCSTGRRQRSICKQLLKK Synthetic peptide Apoptotic inducing Cell viability assay SW-480 Colon cancer 100% cell viability at 5 µM
dbacp04807 N29N PDEDAINNALNKVCSTGRRQRSICKQLLKK Synthetic peptide Apoptotic inducing Cell viability assay SW-480 Colon cancer 40% cell viability at 50 µM
dbacp04812 N29N PDEDAINNALNKVCSTGRRQRSICKQLLKK Synthetic peptide Apoptotic inducing Cell viability assay SW-480 Colon cancer 100% cell viability at 5 µM
dbacp04813 N29N PDEDAINNALNKVCSTGRRQRSICKQLLKK Synthetic peptide Apoptotic inducing Cell viability assay SW-480 Colon cancer 40% cell viability at 50 µM
dbacp04818 N29N PDEDAINNALNKVCSTGRRQRSICKQLLKK Synthetic peptide Apoptotic inducing Cell viability assay SW-480 Colon cancer MIC : 5 µM
dbacp04867 NK-2 KILRGVCKKIMRTFLRRISKDILTGKK NK-lysin Cell membrane disintegration PI-uptake assay SW-480 Leukemia cancer LD50 : 1-4 µM
dbacp05024 Peptide P KWKSFLKTFKSAKKTVLHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay SW-1116 Colorectal cancer IC50 : 11.1 µMo/L
dbacp05092 P6 WYIRKIRRFFKWLKKKLKKK Marine invertebrates Inducing apoptosis MTT assay SW-620 Colorectal cancer Not found
dbacp05943 RGD-La RGDLLRHVVKILEKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay SW-1116 Colorectal cancer 72.69 Inhibition ratio at 50 µg/ml
dbacp05952 RGD-Las RGDLLRHVVKILSKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay SW-1116 Colorectal cancer 81.465 Inhibition ratio at 50 µg/ml
dbacp06248 Temporin-La LLRHVVKILEKYL Temporins family Cell membrane disintegration MTT/MTS assay SW-1116 Colorectal cancer 57.62 inhibition ratio at 50 µg/ml
dbacp06257 Temporin-Las LLRHVVKILSKYL Temporins family Cell membrane disintegration MTT/MTS assay SW-1116 Colorectal cancer 62.73 inhibition ratio at 50 µg/ml
dbacp06737 Aurein 1.2_mutant (Aurm) GLFDIIKKIIKSF Synthetic Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane MTT assay SW-480 Colon Cancer 51.63% cell viability
dbacp06739 Aurein 1.2_R5 (R5-Aur) RRRRRGLFDIIKKIAESF Synthetic Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane MTT assay SW-480 Colon Cancer 43.89% cell viability
dbacp06741 Aurein 1.2_mutant_R5 (R5-Aurm) RRRRRGLFDIIKKIIKSF Synthetic Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane MTT assay SW-480 Colon Cancer 40.62% cell viability
dbacp07085 HB43 FAKLLAKLAKKLL Synthetic Motif-driven membrane insertion triggers cytotoxicity AlamarBlue assay SW-480 Colon Cancer IC50 = 12 ± 4 μM
dbacp07086 HB43 FAKLLAKLAKKLL Synthetic Motif-driven membrane insertion triggers cytotoxicity AlamarBlue assay SW-620 Colon Cancer IC50 = 10 ± 1 μM
dbacp07089 HB43-mut2 FAKLLAKLAKLLK Synthetic Motif-driven membrane insertion triggers cytotoxicity AlamarBlue assay SW-480 Colon Cancer IC50 = 34 ± 2 μM
dbacp07090 HB43-mut2 FAKLLAKLAKLLK Synthetic Motif-driven membrane insertion triggers cytotoxicity AlamarBlue assay SW-620 Colon Cancer IC50 = 40 ± 3 μM
dbacp07093 HB43-mut3 FAKLLAKLARRLL Synthetic Motif-driven membrane insertion triggers cytotoxicity AlamarBlue assay SW-480 Colon Cancer IC50 = 8 ± 1 μM
dbacp07094 HB43-mut3 FAKLLAKLARRLL Synthetic Motif-driven membrane insertion triggers cytotoxicity AlamarBlue assay SW-620 Colon Cancer IC50 = 9 ± 1 μM
dbacp07253 ATX-101 MDRWLVKWKKKRKIRRRRRRRRRRR Synthetic PCNA interference disrupts DNA repair. CCK-8 assay SW-1783 Brain Tumor IC50 = 4.8 ± 0.2 μM
dbacp07287 P264-G274 PARDVLNTTSG Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-480 Colorectal Cancer EC50 = 90.98 ± 0.75 µM
dbacp07288 P264-G274 PARDVLNTTSG Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-620 Colorectal Cancer EC50 = 11.28 ± 0.52 µM
dbacp07289 Loop1-PS2Aa NNETYFNAVKP Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-480 Colorectal Cancer EC50 = 23.76 ± 1.25 µM
dbacp07290 Loop1-PS2Aa NNETYFNAVKP Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-620 Colorectal Cancer EC50 = 106.2 ± 1.67 µM
dbacp07291 Loop2-PS2Aa TYFNAVKPPITA Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-480 Colorectal Cancer EC50 = 92.99 ± 0.98 µM
dbacp07292 Loop2-PS2Aa TYFNAVKPPITA Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-620 Colorectal Cancer EC50 = 15.95 ± 0.69 µM
dbacp07293 Loop1-HCoV-229E FKPQSGGGKCF Alphacoronavirus (HCoV-229E) h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-480 Colorectal Cancer EC50 = 125.0 ± 1.32 µM
dbacp07294 A4W-GGN5 FLGWLFKVASK Gaegurin 5 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-480 Colorectal Cancer EC50 = 98.63 ± 1.17 µM
dbacp07295 A4W-GGN5 FLGWLFKVASK Gaegurin 5 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-620 Colorectal Cancer EC50 = 22.07 ± 1.63 µM
dbacp07948 IL13Rα2 D1 peptide GSETWKTIITKN Synthetic IL13Rα2 blockade inhibits cancer metastasis MTT assay SW-620 Colorectal Cancer inhibited IL13-stimulated cell adhesion
dbacp08040 Silk Fibroin peptide Not Available Silkworm Cocoons SFP induces S-phase cell-cycle arrest MTT assay SW-1990 Pancreatic Cancer IC50 = 8.005 ± 1.34 mg/ml
dbacp08062 TAT-327 RKKRRQRRREFLDCFQKF Peptide-327 Peptide 327 blocks Eps8–EGFR CCK-8 assay SW-620 Colorectal Cancer EC50 = 64.61 ± 1.63 μM